MediPharm Labs and Hybrid Pharm Partner to Offer New Same Day Registration and Delivery Service of Medical Cannabis

NEXT STORY
Fortress Biotech Announces Publication of Study on Targeted Next Generation Sequencing for Newborn Screening of Menkes Disease in Molecular Genetics and Metabolism Reports
PREV STORY
Myriad Launches Proprietary AMPLIFY™ Technology, Further Increasing the Performance of its Prequel™ NIPS Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Diabetes Diagnostics Markets, 2022 – Growing Prominence of Real-Time Glucose Sensing and Monitoring Drive Robust Demand

Dublin, Aug. 23, 2018 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Strategic Business ...

author_avatar
NASDAQ Market News

Madrigal Pharmaceuticals Announces First Patient Dosed in MAESTRO-NAFLD-1, a Second Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Resmetirom (MGL-3196) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Presumed NASH (NASH/NAFLD (non-alcoholic fatty liver disease))

author_avatar
NASDAQ Market News

ONCOTELIC THERAPEUTICS, INC. ANNOUNCED SYNERGY BETWEEN OT-101 AND IL-2 (PROLEUKIN) AT AACR-2021

author_avatar
NASDAQ Market News